Masafumi Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Masafumi Nakamura has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
Masao Tanaka
20 shared publications- Kohei Nakata
Department of Surgery and Oncology, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
14 shared publications - Takao Ohtsuka
Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
14 shared publications - Yoshihiro Miyasaka
Department of Surgery and Oncology Graduate School of Medical Sciences Kyushu University Fukuoka Japan
14 shared publications Shunichi Takahata
13 shared publicationsYasuhisa Mori
11 shared publications
Latest Publications
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Sa1377 - Necroptosis Promotes Cancer Cell Migration and Invasion in Pancreatic Cancer
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Sa1377 - Necroptosis Promotes Cancer Cell Migration and Invasion in Pancreatic Cancer
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1359 - The Role of Cancer-Associated Acinar Atrophy via Adm-Like Lesion in the Invasive Front of Pancreatic Cancer
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1359 - The Role of Cancer-Associated Acinar Atrophy via Adm-Like Lesion in the Invasive Front of Pancreatic Cancer
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB064
AB064. P036. Fat tissue and pancreatic parenchyma play different roles in pancreatic cancer invasion
Background: Although the formation of desmoplasia in the local invasion of pancreatic cancer is one of the important common histological changes during invasion to surrounding tissues including adipose tissues and pancreatic parenchyma. However, the differences and the underlying mechanism in surrounding tissue-specific invasion remain unclear. This study aims to investigate the differences in the mechanisms of local invasion to peripancreatic adipose tissues and pancreatic parenchyma. Methods: We used organotypic fat invasion model and visceral fat transplantation model to investigate the local invasion to peripancreatic adipose tissues. We also analyzed pancreatic tissues from patients and KPC mice with pancreatic cancer and used orthotopic transplantation model to investigate the mechanism of the local invasion to pancreatic parenchyma. Results: In organotypic model, we found that GFP positive adipose tissue-derived stromal cells (ASCs) infiltrated toward cancer cells. In visceral fat transplantation model with cancer cells, the weight of tumors with visceral fat was significantly heavier than the groups without visceral fat (PConclusions: Our data provide the new insight that fat tissue and pancreatic parenchyma play different roles in pancreatic cancer invasion.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB064
AB064. P036. Fat tissue and pancreatic parenchyma play different roles in pancreatic cancer invasion
Background: Although the formation of desmoplasia in the local invasion of pancreatic cancer is one of the important common histological changes during invasion to surrounding tissues including adipose tissues and pancreatic parenchyma. However, the differences and the underlying mechanism in surrounding tissue-specific invasion remain unclear. This study aims to investigate the differences in the mechanisms of local invasion to peripancreatic adipose tissues and pancreatic parenchyma. Methods: We used organotypic fat invasion model and visceral fat transplantation model to investigate the local invasion to peripancreatic adipose tissues. We also analyzed pancreatic tissues from patients and KPC mice with pancreatic cancer and used orthotopic transplantation model to investigate the mechanism of the local invasion to pancreatic parenchyma. Results: In organotypic model, we found that GFP positive adipose tissue-derived stromal cells (ASCs) infiltrated toward cancer cells. In visceral fat transplantation model with cancer cells, the weight of tumors with visceral fat was significantly heavier than the groups without visceral fat (PConclusions: Our data provide the new insight that fat tissue and pancreatic parenchyma play different roles in pancreatic cancer invasion.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB080
AB080. P052. Role of neutrophil extracellular traps (NETs) in pancreatic cancer liver metastasis
Background: Liver metastasis is the major cause of pancreatic ductal adenocarcinoma (PDAC) related death and preventing liver metastases may improve the patient’s survival. Neutrophil extracellular traps (NETs) were identified in 2004 and are extracellular networks that consist of DNA released from neutrophils together with antimicrobial peptides and proteases derived from neutrophil granules. Recently, it was shown that NETs promote various human pathology, such as cancer-associated thrombosis and auto-immune disease and cancer, but the role of NETs in pancreatic cancer progression is not well known. This study aims to investigate the role of NETs in pancreatic cancer liver metastasis using genetically engineered mice that spontaneously develop PDAC and tumor intrasplenic injection mouse model that forms experimental liver metastases. Methods: Two mouse models, spontaneous pancreatic cancer mice KPCL (LSL-Kras G12D/+; LSL-Trp53 R172H/+; LSL-Luciferase; Pdx-1-Cre) mice and tumor splenic injection model were treated with DNase I, NETs inhibitor, and examined the influence of DNase I on invasion and metastasis of pancreatic cancer. Neutrophils isolated from bone marrow of C57BL/6 mouse were co-cultured with pancreatic cancer cells derived from KPC (LSL-Kras G12D/+; LSL-Trp53 R172H/+; Pdx-1-Cre) mouse. Results: KPCL mice treated with DNase I from the 8 weeks of age had significantly longer survival time compared to the control group, and liver metastasis was suppressed. However, liver metastasis was suppressed in the group that started administration from the 13 weeks of age, the survival period was not extended. In the tumor intrasplenic injection model, neutrophils were recruited to the liver micrometastases, and liver metastasis formation was inhibited in the DNase I treated group. In vitro study revealed that cancer cells derived from KPC mice indirectly co-cultured with neutrophils promoted NETs formation. Conclusions: DNase I, a NETs inhibitor, suppressed liver metastasis formation in KPCL mice and tumor intrasplenic injected model, suggesting that NETs promotes liver metastasis in pancreatic cancer.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB080
AB080. P052. Role of neutrophil extracellular traps (NETs) in pancreatic cancer liver metastasis
Background: Liver metastasis is the major cause of pancreatic ductal adenocarcinoma (PDAC) related death and preventing liver metastases may improve the patient’s survival. Neutrophil extracellular traps (NETs) were identified in 2004 and are extracellular networks that consist of DNA released from neutrophils together with antimicrobial peptides and proteases derived from neutrophil granules. Recently, it was shown that NETs promote various human pathology, such as cancer-associated thrombosis and auto-immune disease and cancer, but the role of NETs in pancreatic cancer progression is not well known. This study aims to investigate the role of NETs in pancreatic cancer liver metastasis using genetically engineered mice that spontaneously develop PDAC and tumor intrasplenic injection mouse model that forms experimental liver metastases. Methods: Two mouse models, spontaneous pancreatic cancer mice KPCL (LSL-Kras G12D/+; LSL-Trp53 R172H/+; LSL-Luciferase; Pdx-1-Cre) mice and tumor splenic injection model were treated with DNase I, NETs inhibitor, and examined the influence of DNase I on invasion and metastasis of pancreatic cancer. Neutrophils isolated from bone marrow of C57BL/6 mouse were co-cultured with pancreatic cancer cells derived from KPC (LSL-Kras G12D/+; LSL-Trp53 R172H/+; Pdx-1-Cre) mouse. Results: KPCL mice treated with DNase I from the 8 weeks of age had significantly longer survival time compared to the control group, and liver metastasis was suppressed. However, liver metastasis was suppressed in the group that started administration from the 13 weeks of age, the survival period was not extended. In the tumor intrasplenic injection model, neutrophils were recruited to the liver micrometastases, and liver metastasis formation was inhibited in the DNase I treated group. In vitro study revealed that cancer cells derived from KPC mice indirectly co-cultured with neutrophils promoted NETs formation. Conclusions: DNase I, a NETs inhibitor, suppressed liver metastasis formation in KPCL mice and tumor intrasplenic injected model, suggesting that NETs promotes liver metastasis in pancreatic cancer.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB131
AB131. P107. Prognostic value of preoperative nutritional and immunological factors in patients with pancreatic ductal adenocarcinoma
Background: Preoperative nutritional and immunological patient factors have been found to be associated with prognostic outcomes of malignant tumors; however, the clinical significance of these factors in pancreatic ductal adenocarcinoma (PDAC) remains controversial. The aim of this study is to evaluate the prognostic value of nutritional and immunological factors in predicting survival of patients with PDAC. Methods: Retrospective studies of 329 patients who underwent surgical resection for PDAC and 95 patients who underwent palliative surgery were separately conducted to investigate the prognostic impact of tumor-related factors and patient-related factors including Glasgow Prognostic Score (GPS), modified GPS, prognostic nutritional index (PNI), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio, and lymphocyte/monocyte ratio. Results: In multivariate analysis for patients with surgical resection for PDAC, PNI was an independent factor for overall survival (OS) and disease-free survival. The median OS of patients with PNI ≤45 was significantly shorter than that of patients with PNI >45 (17.5 and 36.2 months, respectively; P5 was significantly shorter than that of patients with NLR ≤5 (2.7 and 8.9 months, respectively; PConclusions: PNI in patients with surgical resection and NLR in patients with palliative surgery for PDAC may be useful as prognostic factors.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB131
AB131. P107. Prognostic value of preoperative nutritional and immunological factors in patients with pancreatic ductal adenocarcinoma
Background: Preoperative nutritional and immunological patient factors have been found to be associated with prognostic outcomes of malignant tumors; however, the clinical significance of these factors in pancreatic ductal adenocarcinoma (PDAC) remains controversial. The aim of this study is to evaluate the prognostic value of nutritional and immunological factors in predicting survival of patients with PDAC. Methods: Retrospective studies of 329 patients who underwent surgical resection for PDAC and 95 patients who underwent palliative surgery were separately conducted to investigate the prognostic impact of tumor-related factors and patient-related factors including Glasgow Prognostic Score (GPS), modified GPS, prognostic nutritional index (PNI), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio, and lymphocyte/monocyte ratio. Results: In multivariate analysis for patients with surgical resection for PDAC, PNI was an independent factor for overall survival (OS) and disease-free survival. The median OS of patients with PNI ≤45 was significantly shorter than that of patients with PNI >45 (17.5 and 36.2 months, respectively; P5 was significantly shorter than that of patients with NLR ≤5 (2.7 and 8.9 months, respectively; PConclusions: PNI in patients with surgical resection and NLR in patients with palliative surgery for PDAC may be useful as prognostic factors.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB104
AB104. P078. Exosomal microRNAs in pancreatic juice have possibility as biomarkers to detect pancreatic ductal adenocarcinoma
Background: Because pancreatic ductal adenocarcinoma (PDAC) is a lethal neoplasm which is often diagnosed late due to difficult early detection, it is crucial to devise biomarkers to detect PDAC. Exosomes are small membrane vesicles secreted from various cells and identified in several body fluids. Recently, some studies have indicated exosomes have a potential to become novel biomarkers. This study aimed to prove the existence of exosomes in pancreatic juice (PJ) and investigate whether exosomal microRNAs (ex-miRs) could be used as biomarkers for PDAC. Methods: PJ was collected by endoscopic retrograde pancreatography in patients with PDAC and chronic pancreatitis (CP). The ultracentrifuge method was applied to extract the exosomes. Relative expression levels of ex-miR21 and ex-miR155 were quantified and their expression levels were compared between PDAC and CP. Results: A total of 35 PJ samples (27 PDACs and 8 CPs) were collected. Presence of exosomes in PJ was determined by electronic microscope and western blot using anti-CD63, CD81, and TSG101 antibody. Relative expression levels of ex-miR21 and ex-miR155 were significantly higher in PDAC than in CP (PConclusions: Ex-miR21 and ex-miR155 in PJ may be potential biomarkers for PDAC.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB104
AB104. P078. Exosomal microRNAs in pancreatic juice have possibility as biomarkers to detect pancreatic ductal adenocarcinoma
Background: Because pancreatic ductal adenocarcinoma (PDAC) is a lethal neoplasm which is often diagnosed late due to difficult early detection, it is crucial to devise biomarkers to detect PDAC. Exosomes are small membrane vesicles secreted from various cells and identified in several body fluids. Recently, some studies have indicated exosomes have a potential to become novel biomarkers. This study aimed to prove the existence of exosomes in pancreatic juice (PJ) and investigate whether exosomal microRNAs (ex-miRs) could be used as biomarkers for PDAC. Methods: PJ was collected by endoscopic retrograde pancreatography in patients with PDAC and chronic pancreatitis (CP). The ultracentrifuge method was applied to extract the exosomes. Relative expression levels of ex-miR21 and ex-miR155 were quantified and their expression levels were compared between PDAC and CP. Results: A total of 35 PJ samples (27 PDACs and 8 CPs) were collected. Presence of exosomes in PJ was determined by electronic microscope and western blot using anti-CD63, CD81, and TSG101 antibody. Relative expression levels of ex-miR21 and ex-miR155 were significantly higher in PDAC than in CP (PConclusions: Ex-miR21 and ex-miR155 in PJ may be potential biomarkers for PDAC.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB025
AB025. S025. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma
Stroma invasion is an important step in pancreatic cancer progression. However, how pancreatic ductal adenocarcinoma (PDAC) with ductal structure invades the surrounding stroma has not been clear. Here, we elucidated the mechanism of stromal invasion of PDAC, using organoids. From resected PDAC specimens, we established human PDAC organoids, which developed ductal and basement membrane (BM) structures. When the organoids were co-cultured with pancreatic stellate cells (PSCs) in a collagen matrix, organoids lost their BM and ductal structures, and invaded collagen matrix more frequently than did mono-cultured organoids. Interestingly, direct contact by PSCs to PDAC organoids was observed before BM destruction. Matrix metalloproteinase (MMP) 2 or membrane type-1 MMP (MT1MMP) knockdown in PSCs significantly attenuated BM destruction by PSCs, and retained the ductal structures in organoids. Our results imply that direct contact by PSCs induces BM destruction and stromal invasion of PDAC via MMP2 which binds to MT1MMP on PSCs.
- 1 April 2018
- Published by AME Publishing Company in Annals of Pancreatic Cancer
- Vol. 1 (1) , AB025
AB025. S025. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma
Stroma invasion is an important step in pancreatic cancer progression. However, how pancreatic ductal adenocarcinoma (PDAC) with ductal structure invades the surrounding stroma has not been clear. Here, we elucidated the mechanism of stromal invasion of PDAC, using organoids. From resected PDAC specimens, we established human PDAC organoids, which developed ductal and basement membrane (BM) structures. When the organoids were co-cultured with pancreatic stellate cells (PSCs) in a collagen matrix, organoids lost their BM and ductal structures, and invaded collagen matrix more frequently than did mono-cultured organoids. Interestingly, direct contact by PSCs to PDAC organoids was observed before BM destruction. Matrix metalloproteinase (MMP) 2 or membrane type-1 MMP (MT1MMP) knockdown in PSCs significantly attenuated BM destruction by PSCs, and retained the ductal structures in organoids. Our results imply that direct contact by PSCs induces BM destruction and stromal invasion of PDAC via MMP2 which binds to MT1MMP on PSCs.
- Open Access
- 1 January 2018
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 79 (1) , 151-157
An Intrapelvic Solitary Fibrous Tumor that Developed as a Sciatic Notch Tumor
症例は41歳,女性.数年前より間欠的な右下肢麻痺と疼痛を認めていた.検診で骨盤内腫瘤を指摘され当院紹介となった.腹部造影CT検査では坐骨切痕を通じて骨盤内外へ進展する腫瘍,いわゆるsciatic notch tumorを認め,生検で孤発性線維性腫瘍(SFT)の診断となった.後腹膜および後方アプローチを併用した腫瘍切除術を施行した.術後は右下肢麻痺の改善を認め,退院時には歩行可能となった.術後3年6カ月経過し,明らかな再発は認めていない.骨盤内SFTは稀な疾患であり,骨盤内外に進展するSFTの本邦報告例は認めていない.骨盤内外に進展する軟部腫瘍に対する外科治療では,解剖学的熟知と高度な手術手技を要し,多方向からのアプローチを用いて十分な視野確保の下に,安全かつ腫瘍学的に十分な腫瘍切除を行う必要がある.今回,われわれは後腹膜および後方アプローチにより完全切除が可能であった骨盤内外へ進展するSFTの1例を経験したので,文献的考察を加えて報告する.
- 1 January 2018
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 79 (1) , 151-157
Open AccessAn Intrapelvic Solitary Fibrous Tumor that Developed as a Sciatic Notch Tumor
症例は41歳,女性.数年前より間欠的な右下肢麻痺と疼痛を認めていた.検診で骨盤内腫瘤を指摘され当院紹介となった.腹部造影CT検査では坐骨切痕を通じて骨盤内外へ進展する腫瘍,いわゆるsciatic notch tumorを認め,生検で孤発性線維性腫瘍(SFT)の診断となった.後腹膜および後方アプローチを併用した腫瘍切除術を施行した.術後は右下肢麻痺の改善を認め,退院時には歩行可能となった.術後3年6カ月経過し,明らかな再発は認めていない.骨盤内SFTは稀な疾患であり,骨盤内外に進展するSFTの本邦報告例は認めていない.骨盤内外に進展する軟部腫瘍に対する外科治療では,解剖学的熟知と高度な手術手技を要し,多方向からのアプローチを用いて十分な視野確保の下に,安全かつ腫瘍学的に十分な腫瘍切除を行う必要がある.今回,われわれは後腹膜および後方アプローチにより完全切除が可能であった骨盤内外へ進展するSFTの1例を経験したので,文献的考察を加えて報告する.
- 1 January 2017
- Published by Japan Pancreas Society in Suizo
- Vol. 32 (1) , 45-49
Early detection of pancreatic cancer concomitant with IPMN using pancreatic juice cytology
我々の施設では他の画像診断法では捉えられないIPMN併存膵上皮内癌はERCP下膵液細胞診でのみ診断可能であると考え,IPMN患者に対して積極的にERCP下膵液細胞診を行っている.実際,これまで経験したIPMN併存膵上皮内癌9例のうち4例をERCPのみで診断した.またworrisome featuresを持つIPMNの中から悪性IPMNを拾い上げるのにもERCP下膵液細胞診が有用である(感度100%,特異度92%).局在がわからないIPMN併存膵上皮内癌の同定には術中残膵洗浄細胞診が有用であるが,洗浄液漏出による術後播種再発や,洗浄細胞診偽陰性の可能性が課題として残る.最近では膵癌を合併しやすいIPMNの特徴としてMUC2陰性,野生型GNASなどが指摘されており,これらを膵癌発症高危険群として重点的にERCP下膵液細胞診を行うことで,膵癌を効率よく早期に診断することができる可能性がある.
- 1 January 2017
- Published by Japan Pancreas Society in Suizo
- Vol. 32 (1) , 45-49
Early detection of pancreatic cancer concomitant with IPMN using pancreatic juice cytology
我々の施設では他の画像診断法では捉えられないIPMN併存膵上皮内癌はERCP下膵液細胞診でのみ診断可能であると考え,IPMN患者に対して積極的にERCP下膵液細胞診を行っている.実際,これまで経験したIPMN併存膵上皮内癌9例のうち4例をERCPのみで診断した.またworrisome featuresを持つIPMNの中から悪性IPMNを拾い上げるのにもERCP下膵液細胞診が有用である(感度100%,特異度92%).局在がわからないIPMN併存膵上皮内癌の同定には術中残膵洗浄細胞診が有用であるが,洗浄液漏出による術後播種再発や,洗浄細胞診偽陰性の可能性が課題として残る.最近では膵癌を合併しやすいIPMNの特徴としてMUC2陰性,野生型GNASなどが指摘されており,これらを膵癌発症高危険群として重点的にERCP下膵液細胞診を行うことで,膵癌を効率よく早期に診断することができる可能性がある.
- Open Access
- 1 January 2017
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 78 (11) , 2551-2557
Metastatic Collision Tumors Consisting of Sigmoid Colon Cancer and Breast Cancer
患者は64歳,女性.S状結腸癌の術前精査中,右乳癌と診断された.同時性肝転移を指摘され,肝生検より乳癌の転移と診断された.また,同時性多発骨転移を認め乳癌の転移と考えられた.転移乳癌に対する全身療法に先立ち,S状結腸癌に対し原発巣切除を施行した.術中所見より両側卵巣転移が疑われたため,卵巣合併切除を行った.術後経過は良好で術後9日目に退院した.病理組織学的検査では,所属リンパ節および両側卵巣に大腸癌と乳癌の衝突癌を認め,現在は乳癌に対して内分泌治療に引き続き化学療法を施行している.衝突癌は重複癌の特殊型であり,大腸癌では原発巣に多いとされ,転移巣での衝突癌は非常に稀である.転移性衝突癌は進行した重複癌で見られ,治療方針に関しては双方の悪性度や進行度,予後を考慮した上で慎重に決定する必要がある.今回,S状結腸癌と乳癌の転移性衝突癌を有する稀な1例を経験したので,文献的考察を加えて報告する.
- 1 January 2017
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 78 (11) , 2551-2557
Open AccessMetastatic Collision Tumors Consisting of Sigmoid Colon Cancer and Breast Cancer
患者は64歳,女性.S状結腸癌の術前精査中,右乳癌と診断された.同時性肝転移を指摘され,肝生検より乳癌の転移と診断された.また,同時性多発骨転移を認め乳癌の転移と考えられた.転移乳癌に対する全身療法に先立ち,S状結腸癌に対し原発巣切除を施行した.術中所見より両側卵巣転移が疑われたため,卵巣合併切除を行った.術後経過は良好で術後9日目に退院した.病理組織学的検査では,所属リンパ節および両側卵巣に大腸癌と乳癌の衝突癌を認め,現在は乳癌に対して内分泌治療に引き続き化学療法を施行している.衝突癌は重複癌の特殊型であり,大腸癌では原発巣に多いとされ,転移巣での衝突癌は非常に稀である.転移性衝突癌は進行した重複癌で見られ,治療方針に関しては双方の悪性度や進行度,予後を考慮した上で慎重に決定する必要がある.今回,S状結腸癌と乳癌の転移性衝突癌を有する稀な1例を経験したので,文献的考察を加えて報告する.